Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Neurooncol. 2015 May 17;124(1):13–22. doi: 10.1007/s11060-015-1807-0

Fig. 1.

Fig. 1

a & b Cell proliferation analysis (MTT Assay) of U87MGEGFRvIII cells (5 × 103 cells/well) (a) and Normal Human Astrocytes (5 × 103 cells/well) (b) after treatment with control (PBS), IONPs (0.3mg/ml), cetuximab (0.3mg/ml) and cetuximab-IONPs (0.3mg/ml) in combination with IR (p<0.05). C. Western blot analysis for expression of cleaved caspase 3 and caspase 3 of U87MGEGFRvIII cells after treatment with control (PBS), IONPs (0.3mg/ml), cetuximab (0.3mg/ml) and cetuximab-IONPs (0.3mg/ml) in combination with IR.